Literature DB >> 31753201

Statins and Cognitive Impairment: Not a Culprit, Protective in Some?

Costantino Iadecola1, Neal S Parikh2.   

Abstract

Entities:  

Keywords:  brain; cognition; dementia; hydroxymethylglutaryl coenzyme A reductase inhibitors; memory; statins

Mesh：

Substances：

Year:  2019        PMID： 31753201      PMCID： PMC7036086          DOI： 10.1016/j.jacc.2019.09.040

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  18 in total

Review 1.  Does statin use cause memory decline in the elderly?

Authors:  Katherine Samaras; Henry Brodaty; Perminder S Sachdev
Journal:  Trends Cardiovasc Med       Date:  2016-03-28       Impact factor: 6.677

2.  Unraveling the Paradox of Statins with Human Neurons: New Leads in Alzheimer's Disease.

Authors:  Joel W Blanchard; Li-Huei Tsai
Journal:  Cell Stem Cell       Date:  2019-03-07       Impact factor: 24.633

3.  Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.

Authors:  Ajay Gupta; David Thompson; Andrew Whitehouse; Tim Collier; Bjorn Dahlof; Neil Poulter; Rory Collins; Peter Sever
Journal:  Lancet       Date:  2017-05-02       Impact factor: 79.321

4.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

5.  Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy.

Authors:  Kang-Ling Wang; Chia-Jen Liu; Tze-Fan Chao; Su-Jung Chen; Cheng-Hsueh Wu; Chi-Ming Huang; Chun-Chin Chang; Ko-Fan Wang; Tzeng-Ji Chen; Shing-Jong Lin; Chern-En Chiang
Journal:  Am J Cardiol       Date:  2013-11-23       Impact factor: 2.778

6.  Comparative effect of statins on the risk of incident Alzheimer disease.

Authors:  Liliya Sinyavskaya; Serge Gauthier; Christel Renoux; Sophie Dell'Aniello; Samy Suissa; Paul Brassard
Journal:  Neurology       Date:  2017-12-15       Impact factor: 9.910

7.  Cholesterol depletion with physiological concentrations of a statin decreases the formation of the Alzheimer amyloid Abeta peptide.

Authors:  Joseph D. Buxbaum; Neil S.M. Geoghagen; Lawrence T. Friedhoff
Journal:  J Alzheimers Dis       Date:  2001-04       Impact factor: 4.472

8.  Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects.

Authors:  Lidia Glodzik; Henry Rusinek; Angela Kamer; Elizabeth Pirraglia; Wai Tsui; Lisa Mosconi; Yi Li; Pauline McHugh; John Murray; Schantel Williams; Ricardo S Osorio; Catherine Randall; Tracy Butler; Anup Deshpande; Shankar Vallabhajolusa; Mony de Leon
Journal:  Alzheimers Dement (Amst)       Date:  2016-04-19

9.  Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?

Authors:  Jana Crum; Jeffrey Wilson; Marwan Sabbagh
Journal:  Alzheimers Res Ther       Date:  2018-10-02       Impact factor: 6.982

10.  Pravastatin and cognitive function in the elderly. Results of the PROSPER study.

Authors:  Stella Trompet; Peter van Vliet; Anton J M de Craen; Jelle Jolles; Brendan M Buckley; Michael B Murphy; Ian Ford; Peter W Macfarlane; Naveed Sattar; Chris J Packard; David J Stott; Jim Shepherd; Eduard L E M Bollen; Gerard J Blauw; J Wouter Jukema; Rudi G J Westendorp
Journal:  J Neurol       Date:  2009-08-04       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.